Medtronic (MDT) Reports RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint

May 18, 2017 5:43 AM EDT Send to a Friend
First-Ever Study on 2.0 mm DES, EuroPCR Late-Breaking Data Show Exceptional Deliverability and No Stent Thrombosis for the Resolute Onyx ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login